Income Statement

($ amounts in millions unless otherwise noted) Year Ended December 31
2018 2017 2016
Net sales 1,961.0 1,878.6 1,770.1
Cost of sales 1,123.4 1,064.8 992.8
Gross profit 837.6 813.8 777.3
Operating expenses:      
Selling, technical, general and administrative 544.8 567.2 596.3
Research and development 44.3 46.4 45.0
Goodwill impairment 46.6
Total operating expenses 589.1 613.6 687.9
Operating profit 248.5 200.2 89.4
Other (expense) income:      
Interest expense, net (311.0) (336.9) (372.3)
Foreign exchange loss (5.5) (53.7) (34.5)
Other income (expense), net 14.8 (70.0) 85.6
Total other expense (301.7) (460.6) (321.2)
Loss before income taxes and non-controlling interests (53.2) (260.4) (231.8)
Income tax (expense) benefit (23.8) 68.6 41.3
Net loss from continuing operations (77.0) (191.8) (190.5)
(Loss) income from discontinued operations, net of tax (242.9) (103.8) 113.8
Net loss (319.9) (295.6) (76.7)
Net income (loss) attributable to non-controlling interests (4.5) (0.6) 3.0
Net loss attributable to stockholders (324.4) (296.2) (73.7)
Gain on amendment of Series B Convertible Preferred Stock 32.9
Net loss attributable to common stockholders (324.4) (296.2) (40.8)
       
(Loss) earnings per share      
Basic from continuing operations (0.27) (0.68) (0.62)
Basic from discontinued operations (0.86) (0.36) 0.45
Basic attributable to common stockholders (1.13) (1.04) (0.17)
       
Diluted from continuing operations (0.27) (0.68) (1.06)
Diluted from discontinued operations (0.86) (0.36) 0.41
Diluted attributable to common stockholders (1.13) (1.04) (0.65)
       
Weighted average common shares outstanding      
Basic 288.2 286.1 243.3
Diluted 288.2 286.1 272.3

Note: This selected data is for information only. For complete consolidated financial statements and important risks that may affect actual results, see SEC Filings.